共 74 条
[1]
Akiskal H.S., Dysthymic and cyclothymic depressions: Therapeutic considerations, J Clin Psychiatry, 55, pp. 46-52, (1994)
[2]
Alvir J.M.J., Lieberman J.A., Safferman A.Z., Schwimmer J.L., Schaaf J.A., Clozapine-induced agranulocytosis, N Engl J Med, 329, pp. 162-167, (1993)
[3]
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, (1987)
[4]
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, (1994)
[5]
Amminger G.P., Resch F., Reimitz J., Friedrich M.H., Nebenworkungen von clozapin in der therapie psychotischer zustandbilder bei jungendlichen: Eine retrospektive klinische studie, Z Kinder Jugendpsychiat, 20, pp. 5-11, (1992)
[6]
Awouters F., Niemegeers C.J.E., Megens A.A.H.P., Janssen P.A.J., Functional interaction between serotonin S-2 and dopamine D-2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine, J Pharmacol Exp Ther, 254, pp. 945-951, (1990)
[7]
Barrickman L., Noyes R., Kuperman S., Schumacher E., Verda M., Treatment of ADHD with fluoxetine: A preliminary trial, J Am Acad Child Adolesc Psychiatry, 30, pp. 762-767, (1991)
[8]
Bersani G., Bressa G.M., MeCo G., Marini S., Pozzi F., Combined serotonin 5-HT2 and dopamine D-2 antagonism in schizophrenia: Clinical, extrapyramidal and neuroendocrine response in a preliminary study with risperidone (R 64 766), Hum Psychopharmacol, 5, pp. 225-231, (1990)
[9]
Birmaher B., Baker R., Hapur S., Quintana H., Ganguli R., Clozapine for the treatment of adolescents with schizophrenia, J Am Acad Child Psychiatr, 31, pp. 160-164, (1992)
[10]
Blanz B., Schmidt M.H., Clozapine for schizophrenia [letter], J Am Acad Child Adolesc Psychiatry, 32, pp. 223-224, (1993)